tiprankstipranks
Trending News
More News >
Bio-Gene Technology Ltd. (AU:BGT)
ASX:BGT
Australian Market

Bio-Gene Technology Ltd. (BGT) Financial Statements

Compare
9 Followers

Bio-Gene Technology Ltd. Financial Overview

Bio-Gene Technology Ltd.'s market cap is currently AU$7.93M. The company's EPS TTM is AU$-0.005; its P/E ratio is -2.13; Bio-Gene Technology Ltd. is scheduled to report earnings on August 25, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueAU$ 0.00AU$ 18.32KAU$ 149.23KAU$ 445.73KAU$ 62.61K
Gross ProfitAU$ -245.78KAU$ -301.45KAU$ -164.04KAU$ 178.59KAU$ -110.59K
Operating IncomeAU$ -3.07MAU$ -3.06MAU$ -3.63MAU$ -3.41MAU$ -2.60M
EBITDAAU$ -2.58MAU$ -2.97MAU$ -3.14MAU$ -2.92MAU$ -2.85M
Net IncomeAU$ -2.58MAU$ -2.41MAU$ -3.10MAU$ -2.91MAU$ -2.40M
Balance Sheet
Cash & Short-Term InvestmentsAU$ 1.14MAU$ 2.21MAU$ 2.99MAU$ 6.34MAU$ 3.93M
Total AssetsAU$ 2.15MAU$ 3.16MAU$ 3.84MAU$ 7.30MAU$ 5.00M
Total DebtAU$ 51.21KAU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00
Net DebtAU$ -1.14MAU$ -2.21MAU$ -2.99MAU$ -6.34MAU$ -3.93M
Total LiabilitiesAU$ 522.98KAU$ 368.45KAU$ 613.88KAU$ 1.03MAU$ 754.57K
Stockholders' EquityAU$ 1.63MAU$ 2.79MAU$ 3.22MAU$ 6.27MAU$ 4.25M
Cash Flow
Free Cash FlowAU$ -2.54MAU$ -2.76MAU$ -3.28MAU$ 36.67KAU$ -1.83M
Operating Cash FlowAU$ -2.54MAU$ -2.75MAU$ -3.28MAU$ 43.52KAU$ -1.83M
Investing Cash FlowAU$ 0.00AU$ -5.70KAU$ 0.00AU$ -6.84KAU$ -3.03K
Financing Cash FlowAU$ 1.47MAU$ 1.98MAU$ -75.00KAU$ 4.41MAU$ 239.88K
Currency in AUD

Bio-Gene Technology Ltd. Earnings and Revenue History

Bio-Gene Technology Ltd. Debt to Assets

Bio-Gene Technology Ltd. Cash Flow

Bio-Gene Technology Ltd. Forecast EPS vs Actual EPS